Form 4: Immunovant's Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Michael Geffner, Immunovant's Chief Medical Officer, sold 2,349 shares of common stock on April 23, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On April 23, 2025, Michael Geffner, the Chief Medical Officer of Immunovant, Inc. (IMVT), sold 2,349 shares of common stock at a price of $14.79 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of 6,250 restricted stock units (RSUs) on April 17, 2025.
- This transaction was mandated by Immunovant's policy requiring tax obligations to be funded through a 'sell to cover' transaction.
- Following the transaction, Geffner directly owns 225,370 shares of Immunovant common stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to an executive's share sale for tax purposes. It doesn't indicate any significant positive or negative sentiment.
Industry Context
Executive share sales are a common occurrence, often related to compensation and tax obligations. The 'sell to cover' mechanism is a standard practice to manage these obligations.
Key Dates
| Date | Description |
|---|---|
| January 17, 2023 | Holder was granted 100,000 restricted stock units (RSUs). |
| January 16, 2024 | Previous Form 3 filed regarding the grant of RSUs. |
| April 19, 2025 | Date of Power of Attorney execution. |
| April 17, 2025 | 6,250 RSUs vested. |
| April 23, 2025 | Michael Geffner sold 2,349 shares of common stock. |
| April 25, 2025 | Date of signature for the Form 4 filing. |
Keywords
Immunovant, IMVT, Michael Geffner, Chief Medical Officer, Form 4, Share Sale, Restricted Stock Units, Tax Withholding, Sell to Cover, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.